"LEO Pharma is using the Accelrys Lab Notebook to support execution and documentation of medicinal chemistry experiments, both single-compound and parallel synthesis," said Dr. Ulrik de Lichtenberg, head of research informatics and data management at LEO Pharma. "We have extended the functionality of the core ELN product by leveraging the Accelrys Enterprise Platform to create an electronic process exactly matched to our scientific workflows. The ELN platform has strengthened our internal knowledge sharing, and at the same time provided us with a seamless process for capturing documentation needed to obtain and defend patents."

As a key application within the Accelrys Process Management and Compliance Suite of software products, the latest release of the Accelrys Electronic Lab Notebook also offers significant synthetic chemistry enhancements and full integration of interactive Pipeline Pilot scientific authoring protocols that speed data access, review and analysis for medicinal, analytical, formulations and process scientists using the notebook.

The AEP provides a broad, secure foundation supporting tighter integration of the latest notebook release with other applications within the Accelrys Process Management and Compliance Suite and with the platform's extensive scientific Component Collections. The integration with the Accelrys Enterprise Platform has been greatly expanded in this latest notebook release, providing industry-leading data analysis and reporting capabilities that deliver improved experiment insight and productivity for virtually any scientific discipline with lower cost of ownership. For example, the platform speeds experiment design and analysis by enabling scientists to register chemical and biological entities directly within the AELN using the Accelrys Chemical Registration or Accelrys Biological Registration applications.

"The latest release of the Accelrys Electronic Lab Notebook moves beyond the paperless lab to a better connected, more harmonized and compliant lab ecosystem extending from research to manufacturing," said Ken Rapp, managing director of Accelrys' analytical, development, quality and manufacturing solutions. "Improved handling of chemistry workflows in accordance with the way bench chemists actually perform their research speeds lab productivity, while automated Pipeline Pilot workflows within the Notebook accelerate product development in Chemistry, Manufacturing and Control."

Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software, supports industries and organizations that rely on scientific innovation to differentiate themselves. The industry-leading Accelrys Enterprise Platform provides a broad and flexible scientific solution optimized to integrate the diversity of science, experimental processes and information requirements across the research, development, process scale-up and early manufacturing phases of product development. By incorporating capabilities in applications for modeling and simulation, enterprise lab management, workflow and automation, and data management and informatics, Accelrys enables scientific innovators to access, organize, analyze and share data in unprecedented ways, ultimately enhancing innovation, improving productivity and compliance, reducing costs and speeding time from lab to market.

Accelrys solutions are used by more than 1,300 companies in the pharmaceutical, biotechnology, energy, chemicals, aerospace, consumer packaged goods and industrial products industries. Headquartered in San Diego, California, USA, Accelrys employs more than 200 full-time PhD scientists. For more information about Accelrys, visit www.accelrys.com.